Micro cell vesicle technology (mCVT): a novel hybrid system of gene delivery for hard-to-transfect (HTT) cells-Reference-Cited by-同舟云学术

Micro cell vesicle technology (mCVT): a novel hybrid system of gene delivery for hard-to-transfect (HTT) cells

Published:2020 Issue:35 Volume:12 Page:18022-18030
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Ou Yi-Hsuan¹²³,Zou Shui¹²³,Goh Wei Jiang¹²³⁴⁵,Chong Suet Yen⁶⁷²³⁸,Venkatesan Gopalakrishnan¹²³,Wacker Matthias G.¹²³,Storm Gerrit⁶⁷²³⁹,Wang Jiong-Wei⁶⁷²³⁸^ORCID,Czarny Bertrand¹⁰¹¹¹²¹³^ORCID,Pastorin Giorgia¹²³⁴⁵^ORCID,Woon Esther C. Y.¹²³¹⁴¹⁵^ORCID

Affiliation:

1. Department of Pharmacy

2. National University of Singapore

3. Singapore

4. NUS Graduate School for Integrative Sciences and Engineering

5. Centre for Life Sciences (CeLS)

6. Department of Surgery

7. Yong Loo Lin School of Medicine

8. Cardiovascular Research Institute (CVRI)

9. Department of Pharmaceutics

10. School of Materials

11. Science and Engineering & Lee Kong Chian School of Medicine (LKCmedicine)

12. Nanyang Technological University

13. Singapore 639798

14. School of Pharmacy

15. University College London

Abstract

A new hybrid gene delivery platform (mCVT) remarkably improves the transfection efficiency of hard-to-transfect (HTT) cells, while preserving excellent biocompatibility.

Funder

Ministry of Education - Singapore

National Medical Research Council

Nanyang Technological University

National University of Singapore

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2020/NR/D0NR03784B

Reference38 articles.